FAMDF
Futura Medical plc
FAMDF
Futura Medical plc
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the consumer healthcare company behind the erectile dysfunction gel Eroxon, has increased the size of its retail share offer after strong demand from
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has passed a series of operational milestones across its sexual health portfolio as it repositions for growth following a strategic review. The AIM-li
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) chief executive Alex Duggan talked with Proactive about the company's new US commercial partnership for...
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) chief executive Alex Duggan talked with Proactive about the company's new US commercial partnership for Eroxon and encouraging new clinical data for it
Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX), the pharmaceutical group, said it intends to appeal a European Patent Office decision to revoke its patent for MED3000, the erectile dysfunction treat
FTSE 100 down 26 points at 10,653 Pub shares rise after England World Cup win Deal news for easyJet, ITV and defence sector UK construction downturn...